Pharmaceutical Investing ObsEva SA Reports Positive Topline Results from IMPLANT2 Phase 3 Clinical Trial of Nolasiban in IVF
Medical Device Investing Predictive Technology Announces Completion of Genotyping in Two Clinical Trials of ARTGuide
Medical Device Investing ChroMedX CEO Lahav Gil Assembles Task-Force to Explore Feasibility and Applications of Automated Ultrafiltration Technology
Medical Device Investing U.S. Patent and Trademark Office has granted to Todos Medical two additional patents
Medical Device Investing ChroMedX Announces In-House Biosensor Manufacturing for Expedited Testing and Refinement; Appoints Edwards as Executive Chairman
Medical Device Investing RepliCel CEO: Anticipating the Approval of Their Dermal Injector, its Impact in Europe and Beyond
Cartier Resources Announces Subscription Agreement for Flow-Through Units Under Its Previously Announced Brokered Offering and Adjustments Further to Tax Measures Unveiled by the Quebec Minister of Finance
